14-day Premium Trial Subscription Try For FreeTry Free
FRA:BV3
Delisted

Bavarian Nordic A/S Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
20.64€
+0 (+0%)
At Close: Dec 22, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 20.64€ 20.64€ Friday, 22nd Dec 2023 BV3.F stock ended at 20.64€. During the day the stock fluctuated 0% from a day low at 20.64€ to a day high of 20.64€.
90 days 20.18€ 21.17€
52 weeks 18.20€ 35.60€

Historical Bavarian Nordic A/S prices

Date Open High Low Close Volume
Oct 13, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 12, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 11, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 10, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 09, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 06, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 05, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 04, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 03, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Oct 02, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Sep 29, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Sep 28, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Sep 27, 2023 20.64€ 20.64€ 20.64€ 20.64€ 0
Sep 26, 2023 21.02€ 21.02€ 20.18€ 20.18€ 6
Sep 25, 2023 21.17€ 21.17€ 21.17€ 21.17€ 375
Sep 22, 2023 20.60€ 20.60€ 20.60€ 20.60€ 375
Sep 21, 2023 21.24€ 21.24€ 20.50€ 20.50€ 130
Sep 20, 2023 21.05€ 21.56€ 21.01€ 21.01€ 1 658
Sep 19, 2023 19.50€ 20.50€ 19.50€ 20.50€ 430
Sep 18, 2023 19.40€ 19.40€ 19.40€ 19.40€ 0
Sep 15, 2023 18.95€ 19.56€ 18.67€ 18.67€ 0
Sep 14, 2023 18.34€ 18.50€ 18.34€ 18.38€ 40
Sep 13, 2023 18.38€ 18.78€ 18.38€ 18.42€ 0
Sep 12, 2023 18.35€ 18.35€ 18.20€ 18.20€ 0
Sep 11, 2023 18.66€ 18.66€ 18.53€ 18.53€ 0
Click to get the best stock tips daily for free!

About Bavarian Nordic A/S

Bavarian Nordic A/S Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BV3.F Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT